Today, Cloroqualone has become a topic of great interest and relevance in different areas of society. Its impact has been felt in various sectors, from culture to technology, politics and economics. As Cloroqualone continues to generate debate and interest, it is crucial to understand its influence on our daily lives. In this article, we will explore the various facets of Cloroqualone and discuss its importance in the current context. From its origins to its evolution, through its implications and challenges, Cloroqualone continues to be a topic of constant study and reflection for academics, experts and the general public.
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | ? |
ATC code |
|
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Elimination half-life | ? |
Excretion | ? |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.042.761 |
Chemical and physical data | |
Formula | C16H12Cl2N2O |
Molar mass | 319.19 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Cloroqualone is a quinazolinone-class GABAergic and is an analogue of methaqualone developed in the 1980s and marketed mainly in France and some other European countries. It has sedative and antitussive properties resulting from its agonist activity at the β subtype of the GABAa receptor and sigma-1 receptor, and was sold either alone or in combination with other ingredients as a cough medicine. Cloroqualone has weaker sedative properties than methaqualone and was sold for its useful cough-suppressing effects, but was withdrawn from the French market in 1994 because of concerns about its potential for abuse and overdose.